Clinical Trials

Showing trials with last updates posted in 2022.

NCT05497076 | UNKNOWN
9 participants

the Efficacy and Safety of Dalpiciclib Combined With Third-generation EGFR-TKI in Patients With EGFR Mutation and Meningial Metastasis in Non-small Cell Lung Cancer Progressing Through Third-generation TKI and Platinum-containing Two-drug Chemotherapy

Study Type:
OBSERVATIONAL
Last Updated:
2022-08-11
Start Date:
2022-09-01
Completion:
2024-01-01
Conditions
  • Non-small Cell Lung Cancer Confirmed by Histopathology or Cytology
  • The TNM (8th) Phase is IV
  • With EGFR Mutations
  • Meningeal Progression Occurred After Previous Platinum-containing Two-drug Chemotherapy and Third-generation EGFR-TKI Treatment
  • Male or Female
  • The Age of 18 Years Old or More
  • ECOG PS 0 to 2 Points
No Results Yet
NCT05485597 | UNKNOWN | NA
15 participants

Myosuit-based Gait Training

Study Type:
INTERVENTIONAL
Last Updated:
2022-08-11
Start Date:
2022-08-01
Completion:
2022-11-30
Conditions
  • Neurologic Gait Disorder
Interventions
  • DEVICE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page